
Warning shots have been fired by both the General Medical Council (GMC) and the Labour Party about the recruitment issues …

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …

A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …

Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …

The measles virus has been eliminated from the UK for the first time in the country’s history, according to the …

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …

A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …

Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …

As a consequence of the triggering of Article 50 and the UK’s exit from the EU, the EMA – currently …

The stakes are high as the UK general election draws ever closer, and the industry has come out in force …

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

The latest edition of Pharmafocus is available to read online now!